Author:
Bafaloukos D,Papadimitriou C,Linardou H,Aravantinos G,Papakostas P,Skarlos D,Kosmidis P,Fountzilas G,Gogas H,Kalofonos C,Dimopoulos A M
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Antman KH, Elias A, Ryan L (1990) Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules. Semin Oncol 17 (Suppl 4): 68–73
2. Balcerzak SP, Benedetti J, Weiss GR, Natale RB (1995) A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study. Cancer 76: 2248–2252
3. Benjamin RS (1987) Grade 3 nausea, vomiting and myelosuppression or progressive, metastatic sarcoma? J Clin Oncol 5: 833–835
4. Briasoulis E, Tzamakou E, Rammou D (1999) Phase I trial and interaction pharmacokinetics of PEG-liposomal doxorubicin and weekly taxol. Br J Cancer 80 (Suppl 2): 63–66
5. Casper ES, Schwartz GK, Sugarman A, Leung D, Brennan MF (1997) Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma. J Clin Oncol 15: 211–2117
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献